Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006421
Filing Date
2017-08-09
Accepted
2017-08-09 16:12:57
Documents
82
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20170630x10q.htm 10-Q 1766933
2 EX-10.1 arlz-20170630ex101786e37.htm EX-10.1 43562
3 EX-31.1 arlz-20170630ex311f9c3c5.htm EX-31.1 15376
4 EX-31.2 arlz-20170630ex312ef13ea.htm EX-31.2 18966
5 EX-32.1 arlz-20170630ex321b6a6d2.htm EX-32.1 11010
6 EX-32.2 arlz-20170630ex3222e80d2.htm EX-32.2 11073
  Complete submission text file 0001558370-17-006421.txt   7563642

Data Files

Seq Description Document Type Size
7 EX-101.INS arlz-20170630.xml EX-101.INS 1617505
8 EX-101.SCH arlz-20170630.xsd EX-101.SCH 59629
9 EX-101.CAL arlz-20170630_cal.xml EX-101.CAL 57532
10 EX-101.DEF arlz-20170630_def.xml EX-101.DEF 229576
11 EX-101.LAB arlz-20170630_lab.xml EX-101.LAB 529910
12 EX-101.PRE arlz-20170630_pre.xml EX-101.PRE 419930
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 171018011
SIC: 2834 Pharmaceutical Preparations